Darvocet and Hypercoagulation - a phase IV clinical study of FDA data

Summary:

Hypercoagulation is reported as a side effect among people who take Darvocet (acetaminophen; propoxyphene hydrochloride), especially for people who are female, 30-39 old, also take Nuvaring, and have Birth control.

The phase IV clinical study analyzes which people have Hypercoagulation when taking Darvocet. It is created by eHealthMe based on reports of 11,339 people who have side effects when taking Darvocet from the FDA, and is updated regularly.

What is Darvocet?

Darvocet has active ingredients of acetaminophen; propoxyphene hydrochloride. It is often used in pain. eHealthMe is studying from 12,131 Darvocet users. Check the latest studies of Darvocet.

What is Hypercoagulation?

Hypercoagulation (increased tendency for clotting of the blood) is found to be associated with 429 drugs and 533 conditions by eHealthMe. Check the latest studies of Hypercoagulation.

On Dec, 24, 2025

11,339 people reported to have side effects when taking Darvocet.
Among them, 15 people (0.13%) have Hypercoagulation.

Among these 15 people:

What is the gender of people who have Hypercoagulation when taking Darvocet? *

female: 85.71 %
male: 14.29 %

What is the age of people who have Hypercoagulation when taking Darvocet? *

What are other drugs people take besides Darvocet? *

What are other side effects people have besides Hypercoagulation? *

Pulmonary Embolism (blockage of the main artery of the lung): 10 people, 66.67%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 9 people, 60.00%
Muscle Strain (an injury to a muscle in which the muscle fibres tear): 6 people, 40.00%
Fainting (loss of consciousness and postural tone): 6 people, 40.00%
Varicose Vein (veins that have become enlarged and tortuous): 6 people, 40.00%
Atelectasis (partial or complete collapse of the lung): 6 people, 40.00%
Stress And Anxiety: 6 people, 40.00%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 5 people, 33.33%
Pneumonia: 5 people, 33.33%
Pain In Extremity: 5 people, 33.33%

What are the existing conditions these people have? *

Birth Control: 8 people, 53.33%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 13.33%
Uterine Haemorrhage (uterine bleeding): 1 person, 6.67%
Pain In Extremity: 1 person, 6.67%
Infarction (obstruction of the blood supply to an organ or region of tissue): 1 person, 6.67%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 6.67%
Headache (pain in head): 1 person, 6.67%
Gait Disturbance: 1 person, 6.67%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 6.67%
Breast Cancer: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Darvocet and have Hypercoagulation?

- Check whether Hypercoagulation is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Darvocet:

Darvocet (12,131 reports)

Hypercoagulation treatments and more:

Hypercoagulation (4,011 reports)

How severe was Hypercoagulation and when was it recovered:

Hypercoagulation in Darvocet

Expand to all the drugs that have ingredients of acetaminophen; propoxyphene hydrochloride:

Hypercoagulation and drugs with ingredients of acetaminophen; propoxyphene hydrochloride

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Darvocet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypercoagulation:

Hypercoagulation (429 drugs)

Browse all the conditions that are associated with Hypercoagulation:

Hypercoagulation (533 conditions)

Drugs similar to Darvocet and Hypercoagulation :

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; propoxyphene hydrochloride (the active ingredients of Darvocet) and Darvocet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.